Ovo Labs
Ovo Labs develops therapeutics designed to improve egg quality and increase the success rates of IVF treatments. The company is currently advancing three egg rejuvenation therapeutics through preclinical development to address age-related fertility decline. Their products target women undergoing fertility treatments, specifically aiming to reduce chromosome segregation errors during egg maturation.
Visit websiteLondon, UK
Healthtech
Biotechnology
Therapeutics
Fertility
Funding summary
- Total raised
- €4.7M
- Funding rounds
- 1
Investors in Ovo Labs
Investors on record for Ovo Labs. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Ovo Labs?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors